BIOLIT ApS: Financial statements 2014
CVR: 10068460
Source: annual report 2014, Danish Business Authority
01/06/2013 – 31/05/2014
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 746,474 and a net result of DKK 616,651 compared with DKK 602,349 the year before. That is a decrease of 18.1% compared with the year before. Equity in the 2014 report amounted to DKK 1,452,494. The solvency ratio was 38.3%.
- Gross Profit
- DKK 746,474
- Profit/Loss
- DKK 616,651
- Equity
- DKK 1,452,494
- Total Assets
- DKK 3,790,237
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 746 t. | 617 t. | 1.5 mio. | - |
| 2013 | - | 911 t. | 602 t. | 836 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees (2006). In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity in the 2025 report amounted to DKK 10,762,624.
